Walleye Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
37,900
+5,000
+15% +$1.71M 0.05% 364
2026
Q1
$11.6M Sell
32,900
-36,700
-53% -$13.1M 0.05% 348
2025
Q4
$22.8M Buy
69,600
+25,000
+56% +$7.93M 0.07% 255
2025
Q3
$12.6M Sell
44,600
-22,700
-34% -$6.58M 0.05% 435
2025
Q2
$18.8M Buy
67,300
+29,100
+76% +$8.24M 0.07% 259
2025
Q1
$11.9M Sell
38,200
-17,400
-31% -$5.14M 0.05% 374
2024
Q4
$14.5M Buy
55,600
+25,400
+84% +$7.54M 0.04% 442
2024
Q3
$9.73M Sell
30,200
-41,500
-58% -$13.6M 0.02% 706
2024
Q2
$22.4M Sell
71,700
-4,000
-5% -$1.18M 0.04% 316
2024
Q1
$21.5M Buy
75,700
+25,900
+52% +$7.58M 0.04% 387
2023
Q4
$14.3M Buy
49,800
+2,900
+6% +$790K 0.03% 498
2023
Q3
$12.6M Buy
46,900
+17,300
+58% +$4.32M 0.03% 447
2023
Q2
$6.57M Sell
29,600
-9,600
-24% -$2.23M 0.02% 586
2023
Q1
$9.48M Buy
39,200
+21,500
+121% +$5.28M 0.14% 156
2022
Q4
$4.65M Sell
17,700
-5,500
-24% -$1.47M 0.08% 282
2022
Q3
$5.23M Buy
+23,200
New +$5.62M 0.1% 219
2020
Q2
Sell
-9,000
Closed -$1.82M 603
2020
Q1
$1.82M Sell
9,000
-29,200
-76% -$6.38M 0.4% 54
2019
Q4
$9.21M Sell
38,200
-54,700
-59% -$12.1M 0.6% 11
2019
Q3
$18M Buy
92,900
+83,600
+899% +$16M 1.07% 2
2019
Q2
$1.71M Buy
9,300
+4,700
+102% +$842K 0.19% 127
2019
Q1
$874K Buy
+4,600
New +$878K 0.14% 207
2018
Q3
$332K Buy
+1,600
New +$315K 0.15% 167

Other funds holding AMGN

Walleye Capital's AMGN Position: Q2 2026 in Review

Walleye Capital increased its Amgen (AMGN) stake by 961,172% in Q2 2026, buying an estimated $82.3M and bringing the position to 240,318 shares worth $87M. The position accounts for 0.31% of the portfolio, ranked #30.

Walleye Capital first reported a position in AMGN in Q2 2019 and has held it in 15 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Walleye Capital held 240,318 shares of Amgen worth $87M as of Q2 2026.
  • Walleye Capital bought 240,293 Amgen shares in Q2 2026, an estimated $82.3M.
  • Amgen made up 0.31% of Walleye Capital's portfolio in Q2 2026, its #30 holding.
  • Walleye Capital first reported a position in Amgen in Q2 2019 and has held it in 15 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.